Filing Details
- Accession Number:
- 0000939767-19-000052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-27 20:30:26
- Reporting Period:
- 2019-02-25
- Accepted Time:
- 2019-02-27 20:30:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 939767 | Exelixis Inc. | EXEL | Services-Commercial Physical & Biological Research (8731) | 043257395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202089 | Charles Cohen | C/O Exelixis, Inc. 1851 Harbor Bay Parkway Alameda CA 94502 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-25 | 11,250 | $4.16 | 11,250 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-02-25 | 15,000 | $4.57 | 26,250 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-25 | 5,271 | $22.18 | 20,979 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | Disposition | 2019-02-25 | 11,250 | $0.00 | 11,250 | $4.16 |
| Common Stock | Option (right to buy) | Disposition | 2019-02-25 | 15,000 | $0.00 | 15,000 | $4.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-05-14 | 2019-05-13 | No | 4 | M | Direct |
| 0 | 2012-05-24 | 2019-05-23 | No | 4 | M | Direct |
Footnotes
- The option, representing the right to purchase a total of 11,250 shares of Exelixis, Inc. common stock, became fully exercisable on May 14, 2009.
- The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 24, 2012.
Billionaire Hedge Funds
